| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0021-9150(90)90108-U |
| P698 | PubMed publication ID | 2102080 |
| P2093 | author name string | L Hughes | |
| C Kelleher | |||
| E B Raftery | |||
| J D Imeson | |||
| P Broadhurst | |||
| P433 | issue | 2-3 | |
| P921 | main subject | coronary artery disease | Q844935 |
| P304 | page(s) | 169-173 | |
| P577 | publication date | 1990-12-01 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Fibrinogen, factor VII clotting activity and coronary artery disease severity | |
| P478 | volume | 85 |
| Q73526445 | Activated factor VII levels in patients with angiographically confirmed coronary artery disease |
| Q53971605 | Activation of the coagulation cascade in untreated primary open-angle glaucoma. |
| Q41341898 | Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris |
| Q47131389 | Association between fibrinogen level and the severity of coronary stenosis in 418 male patients with myocardial infarction younger than 35 years old. |
| Q52005397 | Changes in hemostatic function at times of cyclic variation in occupational stress. |
| Q73250741 | Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin |
| Q40440943 | Clustering of cardiovascular risk factors: Targeting high-risk individuals |
| Q40628124 | Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris |
| Q33738532 | Expanded network of inflammatory markers of atherogenesis: where are we now? |
| Q72049303 | Fibrinogen and Silent Atherosclerosis in Subjects With Cardiovascular Risk Factors |
| Q51022348 | Fibrinogen levels in women having coronary angiography. |
| Q40582669 | Haemostatic function, arterial disease and the prevention of arterial thrombosis |
| Q53345237 | Hemostatic effects of 1 mg daily warfarin on post CABG patients. Post CABG Studies Investigators. |
| Q34096078 | Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism |
| Q36783613 | How it all starts: Initiation of the clotting cascade. |
| Q79718095 | Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism |
| Q35729514 | Plasma fibrinogen and factor VII as risk factors for cardiovascular disease |
| Q84934992 | Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention |
| Q50940398 | Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease. |
| Q74694147 | Predictive value of preprocedural fibrinogen concerning coronary stenting |
| Q36888651 | Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts. |
| Q43588746 | Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men. |
| Q73531127 | The -323Ins10 polymorphism for factor VII is not associated with coronary atherosclerosis in symptomatic men. The REGRESS study group |
| Q41791338 | The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers |
| Q42684656 | Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease |
| Q73118426 | [Blood coagulation, genetics and post-angioplasty restenosis] |
| Q74084731 | [Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy] |
Search more.